Themis Medicare Share Price

    103.76
    +2.99 (2.97%)
    THEMISMED • 02 Sep, 2025 | 03:29 PM
    Buy
    with MTF at1xleverage

    1Y Annualised Return

    -61.81%

    3Y Annualised Return

    6.90%

    5Y Annualised Return

    22.06%

    10Y Annualised Return

    16.27%

    The current prices are delayed, login or Open Demat Account for live prices.

    Themis Medicare Stock Performance

    1W Return3.47
    1Y Return-57.88
    Today's Low100.06
    Prev. Close100.77
    Mkt Cap (Cr.)955.01
    1M Return-1.38
    3Y Return30.30
    52-Week High317
    Open100.77
    PE Ratio0.00
    6M Return-31.70
    Today's High105.1
    52-Week Low98
    Face Value1

    Themis Medicare Company background

    Founded in: 1969
    Themis Medicare Limited was formerly incorporated as Themis Chemicals Limited in 1969. The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics, which was merged with Artemis Pharmaceuticals in April, 1993. Thereafter, the name of the Company was changed to Themis Medicare Limited in 2001. The Company is principally engaged in the business of manufacturing of finished formulations andsynthetic Active Pharmaceutical Ingredients.In Mar.95, the company came out with a public issue equity shares (premium : Rs 110) to finance the expansioncummodernisation of its synthetic bulk drug plant at Vapi, the setting up of a formulation unit at Lilora, Baroda as backward integration and to augment longterm working capital.Total cost of the project was estimated at Rs 17.64 cr. TCL manufactures and sells synthetic bulk drugs and formulations. It operates in the therapeutic segments of antituberculosis, cerebroactivators, bronchodilators, antiasthmatic, anaesthetic and other segments.Antituberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment. TCL has also started manufacturing and exporting fumagillin, an antibacterial drug, for veterinary use for which it has a confirmed buyback arrangement with Chinoin, Hungary.The company with the help of M/s Pharmograd,Moscow a manufacturing unit, is planning to market its AntiT.B.formulation products through the collborators throughout the Russian Federation for trade,tenders and govt.supplies.The Company introduced products like Cardiac and Muscular Relaxant during the year 200102. A wholly owned subsidiary of the Company, Themis Medicare Singapore Pte. Ltd., formed on 22nd May, 2002 in Singapore became operational during the year 200203. M/s. Artemis Biotech Ltd., a Group Company was merged with Themis Medicare Ltd. (the Parent Company) with effect from 1st April 2003. The Joint Venture Company, Richter Themis Medicare (India) Pvt. Ltd. started manufacturing activities at its EOU unit at Vapi effective from March, 2006. The Company started operations of its new Injection Plant at Haridwar for tablets and gel formulation production in 200607. Themiseal, the Companys unique haemostatic and antimicrobial product was launched in the UK, Greece, Cyprus, Jordan, Romania and Indonesia.During the year 201011, a Private Ltd Subsidiary Company in the name and style of Themis Lifestyle Pvt. Ltd was incorporated on 3rd November, 2010 and another Public Ltd Subsidiary Company in the name and style of Artemis Biotech Ltd. was incorporated on 14th January, 2011.During FY 201617, HIDPUL KFT (Hungary), a Wholly Owned Subsidiary of the Company, ceased to be a subsidiary of the Company. Carpo Medical Limited was incorporated as a Joint Venture Company in the United Kingdom in 201617.The Company launched a new product Lenzetto Global brand of Estradiol Novel Drug Delivery System for treatment of Menopausal symptoms in 2023. As part of a strategy to concentrate on both the API and the Hospital Business, the Company demerged the API segment of the Company, including both the API production facilities, to a 100% owned subsidiary company, Themis Lifestyle Private Limited through slump sale in 2023.

    Themis Medicare Financial Highlights


    Themis Medicare reported a Q1 FY 2025-26 revenue of ₹97.58 crore, up 6.1% YoY, with net profit decreased -3.3% to ₹-14.08 crore. For the full year FY2025–2026, revenue reached ₹410.18 crore and profit touched at ₹23.91 crore.

    As of 02 Sep, 2025, Themis Medicare share price is ₹103.8. The stock opened at ₹100.8 and had closed at ₹100.8 the previous day. During today’s trading session, Themis Medicare share price moved between ₹100.06 and ₹105.10, with an average price for the day of ₹102.58. Over the last 52 weeks, the stock has recorded a low of ₹98.00 and a high of ₹317.00. In terms of performance, Themis Medicare share price has declined by 34.3% over the past six months and has declined by 61.81% over the last year.
    Read More
    Themis Medicare SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹48,40,896 (-25.52%)
    Daily SIP of 25,000 would have become 48,40,896 in 1 year with a gain of -16,59,103 (-25.52%)
    View details of Market Depth

    Themis Medicare Fundamental

    Market Cap (in crs)

    955.01

    Face Value

    1

    Turnover (in lacs)

    68.10

    Key Metrics

    Qtr Change %
    New 52W Low in past week
    -23.5
    Dividend yield 1yr %
    0

    Themis Medicare Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Themis Medicare Quarterly Revenue
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    97.58 Cr
    71.7 Cr
    93.81 Cr
    117.01 Cr
    122.99 Cr
    Themis Medicare Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    410.18 Cr
    386.52 Cr
    365.83 Cr
    401.16 Cr
    234.29 Cr
    205.05 Cr
    Themis Medicare Quarterly Net Profit/Loss
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    -14.08 Cr
    -7.75 Cr
    3.08 Cr
    9.87 Cr
    18.71 Cr
    Themis Medicare Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    23.91 Cr
    24.72 Cr
    43.28 Cr
    61.54 Cr
    26.23 Cr
    15.88 Cr

    Themis Medicare Result Highlights

    • Themis Medicare Ltd reported a 0.2% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 20.3%.

    • Its expenses for the quarter were up by 20.2% QoQ and 14.3% YoY.

    • The net profit decreased 314.2% QoQ and decreased 157.6% YoY.

    • The earnings per share (EPS) of Themis Medicare Ltd declined at 1.5 during Q1 FY 2025-26.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Themis Medicare Shareholding Pattern

    Promoter
    67.2%
    Foreign Institutions
    0.1%
    Public
    32.8%
    Promoter
    67.2%
    Foreign Institutions
    0.1%
    Domestic Institutions
    0.1%
    Public
    32.7%
    Promoter
    67.2%
    Foreign Institutions
    0.1%
    Public
    32.8%
    Promoter
    67.2%
    Foreign Institutions
    0.1%
    Public
    32.7%
    Promoter
    67.2%
    Domestic Institutions
    0.1%
    Public
    32.8%
    Promoter
    67.2%
    Public
    32.8%

    Themis Medicare Technical Analysis

    Moving Averages Analysis
    103.76
    Current Price
    Bullish Moving Averages
    5
    Bearish Moving Averages
    11
    5Day EMA
    101.70
    10Day EMA
    102.40
    12Day EMA
    102.90
    20Day EMA
    105.30
    26Day EMA
    107.20
    50Day EMA
    114.60
    100Day EMA
    131.00
    200Day EMA
    158.70
    5Day SMA
    100.80
    10Day SMA
    102.30
    20Day SMA
    104.60
    30Day SMA
    108.20
    50Day SMA
    115.90
    100Day SMA
    125.90
    150Day SMA
    143.80
    200Day SMA
    176.40
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    35868 Rs
    67457 Rs
    Week Rs
    30309 Rs
    53970 Rs
    Month Rs
    59718 Rs
    392836 Rs
    102.97
    Pivot
    Resistance
    First Resistance
    105.89
    Second Resistance
    108.01
    Third Resistance
    110.93
    Support
    First Support
    100.85
    Second support
    97.93
    Third Support
    95.81
    Relative Strength Index
    42.72
    Money Flow Index
    36.21
    MACD
    -4.29
    MACD Signal
    -4.78
    Average True Range
    4.55
    Average Directional Index
    29.30
    Rate of Change (21)
    -3.47
    Rate of Change (125)
    -37.35

    Themis Medicare Latest News

    21 AUG 2025 | Thursday

    Themis Medicare Ltd - 530199 - Business Responsibility and Sustainability Reporting (BRSR)

    19 AUG 2025 | Tuesday

    Themis Medicare Ltd - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    18 AUG 2025 | Monday

    Themis Medicare Ltd - 530199 - Reg. 34 (1) Annual Report.

    View More

    Themis Medicare Share Price FAQs

    Themis Medicare share price is ₹103.76 in NSE and ₹104.2 in BSE as on 2/9/2025.

    Themis Medicare share price in the past 1-year return was -57.88. The Themis Medicare share hit a 1-year low of Rs. 98 and a 1-year high of Rs. 317.

    The market cap of Themis Medicare is Rs. 955.01 Cr. as of 2/9/2025.

    The PE ratios of Themis Medicare is 0 as of 2/9/2025.

    The PB ratios of Themis Medicare is 3.33 as of 2/9/2025

    You can easily buy Themis Medicare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Themis Medicare share price is ₹317 and ₹98 as of 2/9/2025.

    The earnings per share (EPS) of Themis Medicare declined at 1.5 during Q1 FY 2025-26.

    Please be aware that Themis Medicare stock prices are subject to continuous fluctuations due to various factors.

    Open Demat Account
    +91 -

    Popular Stocks
    58.25
    +0.39 (+0.67%)
    122.99
    +2.45 (+2.03%)
    684.40
    -5.75 (-0.83%)
    2,274.20
    -10.00 (-0.44%)
    144.14
    +1.63 (+1.14%)
    331.85
    +16.15 (+5.12%)
    158.39
    +2.22 (+1.42%)
    322.40
    +1.30 (+0.40%)
    376.60
    +2.70 (+0.72%)
    386.05
    +5.50 (+1.45%)
    Top Gainers
    286.70
    +6.85 (+2.45%)
    1,100.80
    +25.10 (+2.33%)
    1,200.90
    +26.50 (+2.26%)
    336.30
    +5.60 (+1.69%)
    158.39
    +2.22 (+1.42%)
    Top Losers
    3,234.50
    -80.90 (-2.44%)
    1,253.70
    -26.20 (-2.05%)
    1,942.50
    -26.10 (-1.33%)
    1,394.20
    -16.80 (-1.19%)
    2,540.00
    -30.20 (-1.18%)
    Open Demat Account
    +91 -